Table 3.

HR (95% CI) and P values for all-cause, cardiovascular, and noncardiovascular mortality per unit hsCRP increase in the NECOSAD cohort and HR (95% CI) and P values for all-cause mortality per unit hsCRP increase in the Swedish cohort

	CCR5 ins/ins	CCR5Δ32
NECOSAD
All-cause mortality
Crude HR	1.52 (1.34 to 1.71)	1.31 (0.93 to 1.84)
P	<0.01	0.13
Adjusted HR	1.34 (1.18 to 1.52)	1.32 (0.89 to 1.97)
P	<0.01	0.17
Cardiovascular mortality
Crude HR	1.47 (1.24 to 1.75)	1.05 (0.68 to 1.61)
P	<0.01	0.83
Adjusted HR	1.30 (1.08 to 1.55)	1.02 (0.61 to 1.68)
P	<0.01	0.95
Noncardiovascular mortality
Crude HR	1.56 (1.31 to 1.86)	1.79 (1.02 to 3.14)
P	<0.01	0.04
Adjusted HR	1.39 (1.16 to 1.66)	2.37 (1.16 to 4.86)
P	<0.01	0.02
Swedish
All-cause mortality
Crude HR	1.40 (1.17 to 1.66)	1.18 (0.82 to 1.69)
P	<0.01	0.36
Adjusted HR	1.18 (0.98 to 1.43)	0.73 (0.46 to 1.15)
P	0.08	0.17

Adjusted for gender, age at inclusion, cardiovascular disease, diabetes, and dialysis modality.